Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1011920230240010017
International Journal of Arrhythmia
2023 Volume.24 No. 1 p.17 ~ p.17
Analysis of clinical risk factors of failed electrical cardioversion in patients with persistent atrial fibrillation or atrial flutter
Kim Ki-Hun

Choi Ha-Young
Park Ji-No
Song Yeo-Jeong
Kim Seung-Hwan
Kim Dong-Kie
Seol Sang-Hoon
Kim Doo-Il
Yang Pil-Sung
Lim Hong-Euy
Park Jun-Beum
Shim Jae-Min
Ahn Jin-Hee
Lee Sung-Ho
Im Sung-Il
Kim Ju-Youn
Abstract
Background : Although rhythm control could be the best for symptomatic atrial fibrillation (AF), some patients fail to achieve sinus rhythm (SR). This study aimed to identify clinical risk factors of failed electrical cardioversion (ECV).

Methods : A total of 248 patients who received ECV for persistent AF or atrial flutter (AFL) were retrospectively reviewed. Patients were divided into three groups: Group 1 maintained SR for?>?1 year, group 2 maintained SR?¡Â?1 year after ECV, and group 3 failed ECV. SR maintenance was assessed using regular electrocardiography or Holter monitoring.

Results : Patients were divided into group 1 (73, 29%), group 2 (146, 59%), and group 3 (29, 12%). The mean age of patients was 60?¡¾?10 years, and 197 (79%) were male. Age, sex, and baseline characteristics were similar among groups. However, increased cardiac size, digoxin use, heart failure (HF), and decreased left ventricular ejection fraction (LVEF) were more common in group 3. Univariate analysis of clinical risk factors for failed ECV was increased cardiac size [hazard ratio (HR) 2.14 (95% confidence interval [CI], 1.06?4.34, p?=?0.030)], digoxin use [HR 2.66 (95% CI, 1.15?6.14), p?=?0.027], HF [HR 2.60 (95% CI, 1.32?5.09), p?=?0.005], LVEF?
Conclusions : Increased cardiac size, digoxin use, HF, LVEF?
KEYWORD
Atrial fbrillation, Atrial futter, Electrical cardioversion
FullTexts / Linksout information
Listed journal information